A phase Ib trial of alpelisib and weekly cisplatin in patients with solid tumor malignancies.
2021
3134Background: The PI3K pathway may represent a mechanism to overcome cisplatin resistance, particularly in human papilloma virus (HPV)-associated tumors. We conducted a phase Ib trial of alpelisi...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI